Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Business delegation from Vietnam visits Resuscitec GmbH

On 19 October, Resuscitec GmbH hosted visitors from Vietnam: 20 members of a business delegation came to the company’s premises in Freiburg. The meeting was organized by the IHK Exportakademie GmbH, which had invited the delegation to Germany as part of the manager training programme of the Federal Ministry of Economics and Climate Protection. Objective of the invitation, which included the inspection of several small and medium-sized enterprises, was: to strengthen the trade relations between Vietnam and Baden-Württemberg.

Christoph Benk, CTO of Resuscitec GmbH, took this opportunity to explain the technical features of the CARL System in detail and to demonstrate its performance as well as the CARL Therapy by means of case studies. Thomas Kraft, CEO, and Jörg Ronde, CFO, then gave the participants an insight into the company in their presentation.

The delegation was made up of members of different medical fields, so the medical device trade was represented as well as hospital management and medical technology. The exchange following the presentations and the concluding tour of the company was correspondingly lively.

< Zurück